chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My daughter had a rash on her legs that looked like a burn. I treated with cortisone and she awoke in the morning with no rash. Then, as the week went on she developed a cold like symtoms. I had her seen at after hours clinic and they treated her as a Upper Respiratory Infection. She had a high fever that I needed to use motrin and Tylenol to control. Finally fever broke, and the next morning she was covered in a rash head to toe, sores in her mouth. I took her to Urgent Care facility and the doctor asked immediately ifshe had her MMR or had been exposed to Measles. She was diagnosed with the Measles on 11/18/14. He left us to watch for repiratory symtoms and keep her hydrated. And he said it will take 3-5 days to clear up. She is still covered fully today, but this would only be day two.
Full body hives, shortness of breath, and racing heart within an hour. Enlarged lymph nodes within one week
erythema, edema, heat, formation of blisters weeping clear fluid, covering entire upper arm of affected side
Sudden onset tinnitus and sensitivity to sound started within a week of getting third vaccination. The hearing sensitivity improved over the course of a few weeks; however I am still experiencing the tinnitus months later. I did not seek treatment initially for fear of not being taken seriously - the symptoms were definitely noticeable, but not inhibiting to my daily life. I did see an Audiologist 4/14/22 due to the continuing tinnitus and she suggested that I submit a report.
Significant swelling L thigh to knee, mom said bruising around injection site. Treated at urgent care, dx with cellulitis, placed on antibiotic, MRSA guidelines for whole family. F/U with PCP on 8/23 improving, no leg swelling or bruising.
The patient came into Primary care for his booster shot on 10/14/2021. The patient presented two different vaccine cards, from two separate locations. I verified in digital vaccination verification system if the additional doses were present as reported in registry of vaccination system.  The patient received first two doses at (Privacy) and the second set of two shots were received at Board of Health. There are no adverse effects to report other than the additional shots.
spasms in her lip; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (spasms in her lip) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced MUSCLE SPASMS (spasms in her lip). At the time of the report, MUSCLE SPASMS (spasms in her lip) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported No treatment medications were reported
Swelling, redness, itching (at times), warm to the touch - Applied ice for the swelling, took Benadryl for the itching, took Tylenol for the discomfort
FAINTING; LOW BLOOD PRESSURE; This spontaneous report received from a consumer concerned multiple patients. The reporter saw this information on the news.  The patient's weight, height, and medical history were not reported. The multiple patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the multiple patient experienced fainting and low blood pressure after getting the covid-19 vaccine. Laboratory data (dates unspecified) included: Blood pressure (NR: not provided) as Low. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fainting and low blood pressure was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210420138; Sender's Comments: 20210420027-covid-19 vaccine ad26.cov2.s-Fainting. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
effected their "cranial nerve VII"; balance was affected; Gastrointestinal issues; Tinnitis; This case was reported by a consumer via call center representative and described the occurrence of nerve injury in a 59-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included irritable bowel syndrome and shingles (28 days prior to the 1st dose).   On 27th March 2020, the patient received Shingrix (intramuscular). On 27th March 2020, 8 hrs after receiving Shingrix, the patient experienced tinnitus. On an unknown date, the patient experienced nerve injury, balance difficulty and gastrointestinal infection nos. The patient was treated with antivirals nos (Antiviral (Drug Name Unknown)). On an unknown date, the outcome of the nerve injury, balance difficulty and gastrointestinal infection nos were unknown and the outcome of the tinnitus was not recovered/not resolved.   It was unknown if the reporter considered the nerve injury, tinnitus, balance difficulty and gastrointestinal infection nos to be related to Shingrix.  Additional details were provided as follows: The patient had Shingles 28 days prior to their 1st dose of Shingrix. Less than a week after receiving the vaccine the patient experienced effect in cranial nerve VII and caused tinnitus. And the tinnitus was present 80 percent of the time and had not recovered from it.  The patient had irritable bowel syndrome that not sure if the dose did or did not affect the gastrointestinal due to the medical condition. The reporter stated that their balance was affected slightly but only noticeable when they did yoga.  The reporter consented to follow up.
BEGINNING ABOUT 1 WEEK AFTER VACCINATION PATIENT BEGAN EXPERIENCING MUSCLE WEAKNESS AND TINGLING IN THE LEFT ARM, HAS PROGRESSIVELY GOTTEN WORSE AND HAS IMPACTED DAY TO DAY ACTIVITY
HCP reports no further AE's.; an expired dose of GARDASIL 9/Dose was administered today (03Mar2022) and expired on 25Feb2022; This spontaneous report was received from a medical assistant and refers to a male patient with an age reported as 13 (units not provided). The patient's pertinent medical history, concomitant medications, past drug reactions or allergies were not provided.   On 03-MAR-2022, the patient was vaccinated with one time dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) 0.5 milliliter (mL) (vaccination scheme frequency, route of administration and anatomical site of application were not provided; lot number S022599 that was verified for syringe formulation with an expiration date reported and established as 25-FEB-2022) (expired product administered) for prophylaxis.  It was stated that the vaccine had not experienced temperatures excursions. No further adverse events (AE's) were reported (no adverse event).
This spontaneous report as received from a certified medical assistant and from a healthcare worker refers to a patient of unknown age and gender. ON 20-AUG-2014 the patient was vaccinated with (Oka/Merck) VARIVAX (dose, units, route of administration, anatomical location were not reported) which had been exposed to a supported temperature excursion on 15-AUG-2014. No adverse events were observed or reported. This is one of several reports from the same reporter. Additional information has been requested.
No adverse effects; administered an expired dose of ZOSTAVAX vaccine; Information has been received from a medical assistant referring to a 74 year old patient of unknown gender. The patient's pertinent medical history, drug reactions/allergies, current condition and concomitant medication were not provided.     On 21-MAR-2019 the patient was as administered an expired dose of zoster vaccine live (ZOSTAVAX) (strength and route were unknown, lot # L006392 and expiration date was on 25-MAY-2016) for prophylaxis (experienced expired product administered). No adverse effects were reported.
Continued pain for over 2 months since the vaccination. It is painful in my left deltoid when I raise my left arm. The pain is about an 8 on a 1-10 scale. It does not last after I put my arm down, but I cannot lift that arm without pain.
phone call from pt 1 1/2 hr p/vax c/o arms tingling & numbness; 230PM phone call from pt face flushed, very sleepy; 13AUG92 to MD who said was allergic reaction;
bilat knee pain, stiffness & heaviness of lower legs all c/o -no fever, no edema, erythema or inc warmth;lt patella tendonitis noted on exam;
Pulmonary embolism; Thrombosis; This case was received via  VAERS (Reference number: 1350684) on 15-Jun-2021 and was forwarded to Moderna on 15-Jun-2021.    This regulatory authority case was reported by an other health care professional and describes the occurrence of PULMONARY EMBOLISM (Pulmonary embolism) and THROMBOSIS (Thrombosis) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     The patient's past medical history included Irritable bowel syndrome and Glucose tolerance impaired. Concomitant products included LORATADINE, PSEUDOEPHEDRINE SULFATE (CLARITIN-D) and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 22-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-May-2021, the patient experienced PULMONARY EMBOLISM (Pulmonary embolism) (seriousness criteria hospitalization, medically significant and life threatening) and THROMBOSIS (Thrombosis) (seriousness criteria hospitalization, medically significant and life threatening). At the time of the report, PULMONARY EMBOLISM (Pulmonary embolism) and THROMBOSIS (Thrombosis) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-May-2021, Angiogram: abnormal (abnormal) Angiogram peripheral abnormal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that the patient was seen in emergency room (ER) with left lower extremity blood clot. No treatment information provided. Action taken with mRNA-1273 was not applicable.  Company comment Very limited information regarding the events has been provided at this time. Further information is not expected.; Sender's Comments: Very limited information regarding the events has been provided at this time. Further information is not expected.
Heavy/severe menstruation that began early. (Expected menses 4/20-4/25, arrived 4/12) Excessive blood loss especialy on 4/13 in the  late afternono (4pm - 5:30pm)
Patient is having pain in arm and shoulder for 14 days, she is having problems lifting her arm.
Patient got first dose of Moderna and second dose of Pfizer.  Patient was directed to the Moderna line.  She ducked under the delineator into another lane that was Pfizer because it was shorter.  When Registration Tech checked her in she stated she was getting Pfizer. When Vaccinator asked her which vaccine she was getting she said Pfizer.  After getting shot she realized mistake and alerted staff.  No adverse symptoms arose during wait period
Pt reports testing negative for covid 19 the day of her first pfizer  injection. Began with fever and chills the following day. Tested positive  for covid 19 today; 3 days after vaccine
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Adverse event after getting vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Adverse event after getting vaccine). At the time of the report, VACCINATION COMPLICATION (Adverse event after getting vaccine) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was provided. No treatment information was mentioned.
3 hours of uncontrollable shaking starting at 2 am Friday. 3 hours Extreme painful urination. Total body aches, joint pain, 3 days insomnia. 1 1/2 days Fever, headaches, Neck/shoulder pain.  3 days intermittent shooting pain left side of head. Still feeling somewhat tired and not 100%  as of this report but getting better each day.  Took Tylenol and let it ride its course.
experienced a rash; arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm was sore) and VACCINATION SITE RASH (experienced a rash) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039KZOA and 004M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (arm was sore). On an unknown date, the patient experienced VACCINATION SITE RASH (experienced a rash). At the time of the report, VACCINATION SITE PAIN (arm was sore) outcome was unknown and VACCINATION SITE RASH (experienced a rash) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.
Chills (felt a lot colder); Headache; Reaction was slower fatigue / fatigue past a week after getting; Disorientation; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Mar-2021. The most recent information was received on 17-Jul-2021 and was forwarded to Moderna on 17-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DISORIENTATION (Disorientation), CHILLS (Chills (felt a lot colder)), HEADACHE (Headache) and FATIGUE (Reaction was slower fatigue / fatigue past a week after getting) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 023M21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma since 26-Jul-1998, Allergy to animal (Allergy to cats), Pollen allergy, Grass allergy and Dust allergy. Concomitant products included MULTIVITAMIN GUMMY BEARS from 20-May-2020 to an unknown date for an unknown indication.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced DISORIENTATION (Disorientation). On 03-Mar-2021, the patient experienced CHILLS (Chills (felt a lot colder)), HEADACHE (Headache) and FATIGUE (Reaction was slower fatigue / fatigue past a week after getting). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ACETYLSALICYLIC ACID (ALKA SELTZER [ACETYLSALICYLIC ACID]) at an unspecified dose and frequency. On 07-Mar-2021, HEADACHE (Headache) had resolved. On 20-Mar-2021, FATIGUE (Reaction was slower fatigue / fatigue past a week after getting) had resolved. At the time of the report, DISORIENTATION (Disorientation) had not resolved and CHILLS (Chills (felt a lot colder)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-257958 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Added medical history and concomitant medication. On 17-Jul-2021: The start date and stop date of the event (Fatigue) was changed.
VOMITING; HEADACHE; NAUSEA; TIREDNESS; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 180Z068, and batch number: 180Z068 expiry: UNKNOWN) dose was not reported, administered on 18-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced vomiting. On MAR-2021, the subject experienced headache. On MAR-2021, the subject experienced nausea. On MAR-2021, the subject experienced tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, nausea, vomiting and tiredness was not reported. This report was non-serious.
This spontaneous report as received from a physician refers to a 50 year old female patient. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On an unknown dates, the patient was vaccinated with 3 doses of VARIVAX (Merck) and with one dose of ZOSTAVAX (lot numbers and expiration dates were not provided). The patient received the doses due to having negative titers for varicella. On an unknown date after receiving the vaccinations, the patient did not seroconvert. The outcome of the event was not reported. The relatedness between the event and VARIVAX (Merck) and ZOSTAVAX was not reported. Additional information has been requested.
Following administration of vaccination, the patient was reported to have experienced a drop in blood pressure within 15 minutes of the vaccination. BP was reported by the nurse to be 80/50. Patient was alert and reported feeling well despite the hypotension. The patient was placed under further observation.
First shot -  Only symptom was a sore arm two hours after injection and lasted 3 days. Second shot - Symptoms included sore arm at site of injection, fever, chills, swollen lymph nodes. Arm was sore for on the first day, two hours after injections, and lasted 3 days. Fever (highest was 101 degrees F) and chills started on the second day and lasted ~24 hours. Fever (100 degrees F) persisted on third day. Swollen lymph nodes appeared and were noticeable on the third day on the left armpit (side of injection) and on the left side of the neck.
blurry vision, sweating, ringing in ears, dry mouth, slight headache, dizziness
Systemic: Tingling (specify: facial area, extemities)-Medium, Additional Details: Tingling in upper arm and forearm of injection arm. Advised patient to call doctor
SEVERE chills and body aches, fever 99.5, mouth breathing, sweating.
pregnant; bruising on injection site; tenderness on injection site; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 15-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (pregnant). On 15-Jan-2021, EXPOSURE DURING PREGNANCY (pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 15-Jan-2021, the patient had little bit of tenderness and bruising on the injection site for a day or two. Concomitant medications were not provided. Treatment information was not reported.; Sender's Comments: This is a case of product exposure during pregnancy with associated AEs of Vaccination Site Tenderness and Vaccination Site Bruising for this female of unknown age. Patient did not provide consent for follow up.
1) Given in right shoulder not left as was supposed to, due to me being right hand dominant.  2) Within a couple of hours my right arm was mostly unusable and I had to drive.  3) By evenning, I had to call the on-call person because my right arm just hung by my side and was completely unusable; pain, shoulder swelling and hardness, minor effect on the bicep.  A steroid was ordered.  4) By Saturday morning redness had started to appear on the shoulder, and right bicep, along with more swelling and pain.  5) The steroid itself posed issues; severe jitters which I was not told about before hand.  6) Injection site is still somewhat painful while the lower right bicep cannot be taxed; weakness, spasms and pain.  7) These people are aware of it but choose to take a passive role for unrelated reasons.
Dizziness; This is a spontaneous report from a contactable consumer reporting for the mother. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number was not reported), via an unspecified route of administration on 14Jul2021 as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient took the vaccine on 14Jul2021 and she was experiencing side effects. It was reported that patient was in like lot of pain and then cleared as she had no pain, just dizziness in Jul2021. The outcome of event was unknown.  Information on the lot/batch number has been requested.
Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No medical history reported.     On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm pain). At the time of the report, PAIN IN EXTREMITY (Arm pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant medications are provided.
Information has been received from a health professional concerning a 10 year old male pt who was vaccinated with a dose of varicella virus vaccine live. Subsequently, on approx 03May04, the pt developed breakthrough chickenpox with less than 50 lesions. Follow up information indicated that there was no a single report of adverse reaction following varicella vaccination. The reporter indicated that 49 other pt's developed breakthrough cases of chickenpox (WAES0404USA02615, WAES0405USA00572, WAES0405USA00573, WAES0405USA00574, WAES0405USA00575, WAES0405USA00576, WAES0405USA00577, WAES0405USA00578, WAES0405USA00579, WAES0405USA00580, WAES0405USA00581, WAES0405USA00582, WAES0405USA00583, WAES0405USA00584, WAES0405USA00585, WAES0405USA00586, WAES0405USA00587, WAES0405USA00588, WAES0405USA00589, WAES0405USA00590, WAES0405USA00591, WAES0405USA00592, WAES0405USA00593, WAES0405USA00594, WAES0405USA00595, WAES0405USA00596, WAES0405USA00597, WAES0405USA00598, WAES0405USA00599, WAES0405USA00600, WAES0405USA00601, WAES0405USA00602, WAES0405USA00603, WAES0405USA00604, WAES0405USA00605, WAES0405USA00606, WAES0405USA00607, WAES0405USA00608, WAES0405USA00609, WAES0405USA00610, WAES0405USA00611, WAES0405USA00612, WAES0405USA00613, WAES0405USA00614, WAES0405USA00615, WAES0405USA00616, WAES0405USA00617, WAES0405USA00619). No additional information is expected.
severe h/a onset 3AUG hosp 6AUG95 dx meningitis-d/c 9AUG(5;dx attributed to having recv MMR vax 3AUG95;